These data are supported by recent work in glioblastoma which has shown that inhibition of the MIF/CD74 axis with anti-CD74 inhibitor Ibudilast reduces the monocytic subset of MDSCs and enhances intratumoral CD8 T cell activity [35]. Here, CD8A is linked to glioblastoma.